LIfT Biosciences is preclinical UK & EU based Biotech developing an innate allogeneic first-in-class neutrophil based cell therapy platform called N-LIfT (Neutrophil based Leukocyte Infusion Therapy).
Our mission is to bring affordable curative therapies to patients with solid tumours with high unmet medical need, such as pancreatic cancer. The company was set up to develop a new type of adaptable cell therapy with a broad ...
LIfT Biosciences is preclinical UK & EU based Biotech developing an innate allogeneic first-in-class neutrophil based cell therapy platform called N-LIfT (Neutrophil based Leukocyte Infusion Therapy).
Our mission is to bring affordable curative therapies to patients with solid tumours with high unmet medical need, such as pancreatic cancer. The company was set up to develop a new type of adaptable cell therapy with a broad killing mechanism that continues to kill even as the tumour adapts.
Sponsored Ad
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.